A number of experimental evidence has shown that FGF-21 may involve in key etiological pathways leading to diabetes development such as regulation of lipid homeostasis [22], inflammation [23], and development of NAFLD [9]. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.